Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms

Clinical Nephrology

Volumn 74, Issue 6, 2010, Pages 485-490

  Palmisano, A ^a   Corradi, D ^a   Carnevali, M L ^a   Alberici, F ^a   Silini, E M ^a   Gatti, R ^a   Allegri, L ^a   Buzio, C ^a   Vaglio, A ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

IgG4; Membranous nephropathy; Periaortitis; Retroperitoneal fibrosis; Sialoadenitis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISOLONE;

ABDOMINAL AORTA ANEURYSM; ACUTE KIDNEY FAILURE; AGED; AORTITIS; ARTICLE; BLOOD VESSEL BIOPSY; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HLA SYSTEM; HUMAN; HYDRONEPHROSIS; INFLAMMATORY INFILTRATE; KIDNEY FIBROSIS; KIDNEY TUBULE BASEMENT MEMBRANE; LEG THROMBOSIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PAROTID ENLARGEMENT; PROTEINURIA; RENAL ARTERY ANEURYSM; SCLEROSIS; SIALOADENITIS; URETER STENT; VARICOCELE;

EID: 78649823505     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74485     Document Type: Article

References (30)

1. Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol. 2005; 17: 34-40.
2. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006; 367: 241-251.
3. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 14: 3948-3955.
4. Costanzi S, Zoli A, Ferraro PM et al. A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. Clin Nephrol. 2008; 70: 172-175.
5. Kitagawa S, Zen Y, Harada K et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol. 2005; 29: 783-791.
6. Kuroki A, Iyoda M, Shibata T et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005; 68: 302-310.
7. Famularo G, Palmisano A, Afeltra A et al. Retroperitoneal fibrosis associated with psoriasis: a case series. Scand J Rheumatol. 2009; 38: 68-69.
8. Martorana D, Vaglio A, Greco P et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006; 55: 126-130.
9. Vaglio A, Manenti L,Allegri Let al. ANCA-positive periaortic vasculitis: does it fallwithin the spectrum of vasculitis? J Intern Med. 2002; 251: 268-271.
10. Vaglio A, Corradi D, Manenti L et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med. 2003; 114: 454-462.
11. Vaglio A, Palmisano A, Ferretti S et al. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature. Rheumatology (Oxford). 2008; 47: 315-318.
12. Bashour B. Systemic lupus erythematosus with retroperitoneal fibrosis and thrombosis of the inferior vena cava. South Med J. 1993; 86: 1309-1310.
13. Katano K, Hayatsu Y, Matsuda T et al. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol. 2007; 68: 308-314.
14. Katz SM, Bates O, Yudis M et al. Immune complex glomerulonephritis in a case of retroperitoneal fibrosis. Am J Clin Pathol. 1977; 67: 436-439.
15. Lipman RL, Johnson B, Berg G et al. Idiopathic retroperitoneal fibrosis and probable systemic lupus erythematosus. JAMA. 1966; 196: 1022-1024.
16. Martinez-Odriozola P, Gutierrez-Macias A, Moina Eguren I et al. Association of idiopathic retroperitoneal fibrosis, rapidly progressive glomerulonephritis and antiproteinase 3 antineutrophil cytoplasmic antibodies (anti PR3-ANCA). Clin Nephrol. 2008; 70: 251-254.
17. Mercadal L, Martinez F, Barrou B et al. Retroperitoneal fibrosis and membranous nephropathy. Clin Nephrol. 2000; 53: 71-74.
18. Moroni G, Faricciotti A, Cappelletti M et al. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents. Nephrol Dial Transplant. 1999; 14: 1303-1305.
19. Shirota S, Tsuchiya K, Takada M et al. Retroperitoneal fibrosis associated with membranous nephropathy effectively treated with steroids. Intern Med. 2002; 41: 20-25.
20. ter Maaten JC, Franssen CF, Daenekindt AA et al. Triple Wegener's granulomatosis in the urogenital tract. Nephron. 1993; 63: 358-359.
21. Wallijn E, Renders G, Vereecken L. Urological complications following aortofemoral bypass graft. Br J Urol. 1975; 47: 617-621.
22. Zabetakis PM, Novich RK, Matarese RAet al. Idiopathic retroperitoneal fibrosis: a systemic connective tissue disease? J Urol. 1979; 122: 100-102.
23. Corradi D, Maestri R, Palmisano A et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007; 72: 742-753.
24. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol. 2006; 30: 1472-1477.
25. Cornell LD, Chicano SL, Deshpande V et al. Pseudotumors due to IgG4immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007; 31: 1586-1597.
26. Saeki T, Nishi S, Ito T et al. Renal lesions in IgG4-related systemic disease. Intern Med. 2007; 46: 1365-1371.
27. Zen Y, Fujii T, Harada K et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007; 45: 1538-1546.
28. Klouda PT,Manos J, Acheson EJ et al. Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet. 1979; 2: 770-771.
29. Neubert K, Meister S, Moser K et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med. 2008; 14: 748-755.
30. Perry DK, Burns JM, Pollinger HS et al. Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant. 2009; 9: 201-209.